Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-14 1:43 pm Sale | 2025-06-30 | 13G | Maze Therapeutics, Inc. MAZE | Frazier Life Sciences Public Fund, L.P. | 3,352,915 7.700% | -1,098,424 (-24.68%) | Filing History |
| 2025-08-14 11:46 am Purchase | 2025-03-31 | 13G | Maze Therapeutics, Inc. MAZE | JANUS HENDERSON GROUP PLC JHG | 2,625,089 6.000% | 126,978 (+5.08%) | Filing History |
| 2025-08-14 08:48 am Purchase | 2025-06-30 | 13G | Maze Therapeutics, Inc. MAZE | Deep Track Capital LP | 3,948,910 9.020% | 925,426 (+30.61%) | Filing History |
| 2025-05-15 5:05 pm Purchase | 2025-03-31 | 13G | Maze Therapeutics, Inc. MAZE | ARCH Venture Fund X L.P. | 4,120,053 9.400% | 4,120,053 (New Position) | Filing History |
| 2025-05-14 4:10 pm Purchase | 2025-03-31 | 13G | Maze Therapeutics, Inc. MAZE | Matrix Capital Management Company LP | 2,486,184 5.700% | 2,486,184 (New Position) | Filing History |
| 2025-05-14 11:48 am Purchase | 2025-03-31 | 13G | Maze Therapeutics, Inc. MAZE | JANUS HENDERSON GROUP PLC JHG | 2,498,111 5.700% | 2,498,111 (New Position) | Filing History |
| 2025-05-09 4:15 pm Purchase | 2025-03-31 | 13G | Maze Therapeutics, Inc. MAZE | GV 2019 L.P. | 2,412,471 5.500% | 2,412,471 (New Position) | Filing History |
| 2025-05-09 4:15 pm Purchase | 2025-01-31 | 13G | Maze Therapeutics, Inc. MAZE | Third Rock Ventures IV L.P. | 6,073,958 13.900% | 6,073,958 (New Position) | Filing History |
| 2025-04-29 09:59 am Purchase | 2025-04-25 | 13G | Maze Therapeutics, Inc. MAZE | Frazier Life Sciences Public Fund, L.P. | 4,451,339 10.200% | 322,339 (+7.81%) | Filing History |
| 2025-04-29 09:58 am Purchase | 2025-03-31 | 13G | Maze Therapeutics, Inc. MAZE | Frazier Life Sciences Public Fund, L.P. | 4,129,000 9.400% | 935,100 (+29.28%) | Filing History |
| 2025-02-10 10:55 am Purchase | 2025-02-03 | 13G | Maze Therapeutics, Inc. MAZE | Frazier Life Sciences Public Fund, L.P. | 3,193,900 7.300% | 3,193,900 (New Position) | Filing History |
| 2025-02-07 4:30 pm Purchase | 2025-01-31 | 13G | Maze Therapeutics, Inc. MAZE | Deep Track Capital LP | 3,023,484 6.910% | 3,023,484 (New Position) | Filing History |
| 2025-02-07 4:01 pm Unchanged | 2025-01-31 | 13G | Maze Therapeutics, Inc. MAZE | Foresite Capital Fund IV, L.P. | 2,457,108 5.600% | 0 (Unchanged) | Filing History |
| 2025-02-07 4:01 pm Purchase | 2025-01-31 | 13G | Maze Therapeutics, Inc. MAZE | Foresite Capital Fund IV, L.P. | 2,457,108 5.600% | 2,457,108 (New Position) | Filing History |